Skip to content
Boca Raton City Online – Lifestyle
Author:
PMGC Holdings Inc.
NorthStrive Biosciences Announces Launch of EL-32 Preclinical Study Evaluating Muscle Preservation in GLP-1 Weight Loss Therapy
March 10, 2026
PMGC Holdings Inc. Announces Anticipated Reverse Stock Split
March 9, 2026
NorthStrive Biosciences Files 10 U.S. Patent Applications for EL-22 and EL-32 Targeting Muscle Growth and Yield Enhancement in Farmed Animals
March 7, 2026
NorthStrive Biosciences Signs Definitive License Agreement for Commercialization of EL-22 and EL-32, a Myostatin-Engineered Probiotic for Muscle Preservation in Animal Health
March 6, 2026
NorthStrive Biosciences Announces Progress Updates to Phase III Timeline for AI-Driven Drug Discovery Program with Yuva Biosciences
March 5, 2026
←
Previous Page
1
2
3